Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Cervical cancer burden and prevention strategies: Asia Oceania perspective.

Garland SM, Bhatla N, Ngan HY.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1414-22. doi: 10.1158/1055-9965.EPI-12-0164. Review.

2.

Recommendations for cervical cancer prevention in Asia Pacific.

Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX.

Vaccine. 2008 Aug 19;26 Suppl 12:M89-98. doi: 10.1016/j.vaccine.2008.06.020.

PMID:
18945418
3.

Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.

Rogovskaya SI, Shabalova IP, Mikheeva IV, Minkina GN, Podzolkova NM, Shipulina OY, Sultanov SN, Kosenko IA, Brotons M, Buttmann N, Dartell M, Arbyn M, Syrjänen S, Poljak M.

Vaccine. 2013 Dec 31;31 Suppl 7:H46-58. doi: 10.1016/j.vaccine.2013.06.043.

PMID:
24332297
4.

The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference.

Garland S, Park SN, Ngan HY, Frazer I, Tay EH, Chen CJ, Bhatla N, Pitts M, Shin HR, Konno R, Smith J, Pagliusi S, Park JS.

Vaccine. 2008 Oct 9;26(43):5435-40. doi: 10.1016/j.vaccine.2008.07.077. Epub 2008 Aug 14.

PMID:
18706952
5.

Cervical cancer burden and prevention activities in Europe.

Kesic V, Poljak M, Rogovskaya S.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1423-33. doi: 10.1158/1055-9965.EPI-12-0181. Review.

6.

Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.

Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.

Vaccine. 2008 Aug 19;26 Suppl 12:M80-8. doi: 10.1016/j.vaccine.2008.05.041.

PMID:
18945417
7.

[Prevention of cervical cancer (II): prophylactic HPV vaccination, current knowledge, practical procedures and new issues].

Monsonego J.

Presse Med. 2007 Apr;36(4 Pt 2):640-66. Epub 2007 Mar 12. Review. French. Erratum in: Presse Med. 2007 Jul-Aug;36(7-8):1150-1.

PMID:
17350792
8.

The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.

Brinkman JA, Caffrey AS, Muderspach LI, Roman LD, Kast WM.

Eur J Gynaecol Oncol. 2005;26(2):129-42. Review.

PMID:
15857016
9.

Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.

Rambout L, Hopkins L, Hutton B, Fergusson D.

CMAJ. 2007 Aug 28;177(5):469-79. Epub 2007 Aug 1. Review.

10.

An overview on the implementation of HPV vaccination in Europe.

Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, Panatto D, Gasparini R, Boccalini S.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:128-35. Epub 2011 Jan 1. Review.

PMID:
21245659
11.

Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.

Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM.

Vaccine. 2008 Aug 19;26 Suppl 12:M43-52. doi: 10.1016/j.vaccine.2008.05.005. Review.

PMID:
18945413
12.
13.

Human papillomavirus infection and cervical cancer prevention in Japan and Korea.

Konno R, Shin HR, Kim YT, Song YS, Sasagawa T, Inoue M, Park JS.

Vaccine. 2008 Aug 19;26 Suppl 12:M30-42. doi: 10.1016/j.vaccine.2008.05.006.

PMID:
18945412
14.

Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?

Saleem A, Tristram A, Fiander A, Hibbitts S.

Minerva Med. 2009 Dec;100(6):503-23. Review.

PMID:
20010484
15.

[Cervical cancer prevention: the impact of HPV vaccination].

Monsonégo J.

Gynecol Obstet Fertil. 2006 Mar;34(3):189-201. Epub 2006 Mar 10. Review. French.

PMID:
16529969
16.

Primary and secondary prevention of cervical cancer.

Grce M.

Expert Rev Mol Diagn. 2009 Nov;9(8):851-7. doi: 10.1586/erm.09.64. Review.

PMID:
19895230
17.
18.
19.

A critical assessment of screening methods for cervical neoplasia.

Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S.

Int J Gynaecol Obstet. 2005 May;89 Suppl 2:S4-S12. Review.

PMID:
15823266
20.

Recommendations for cervical cancer prevention in Latin America and the Caribbean.

Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX.

Vaccine. 2008 Aug 19;26 Suppl 11:L96-L107. doi: 10.1016/j.vaccine.2008.05.062. Review.

PMID:
18945407
Items per page

Supplemental Content

Write to the Help Desk